Using n-3 DPA-derived Resolvins for Cardiovascular Diseases

Using n-3 DPA-derived Resolvins for Cardiovascular Diseases

Biopharma Using n-3 DPA-derived Resolvins for Cardiovascular Diseases   A novel therapeutic strategy, using n-3 DPA-derived resolvins to treat or prevent cardiovascular disease. Circadian rhythms play a key role in regulating various physiological functions, including...
Repurposing an anti-cancer agent to treat heart failure

Repurposing an anti-cancer agent to treat heart failure

Biopharma Repurposing an anti-cancer agent to treat heart failure   A novel method for the prevention and treatment of heart failure, using αvβ3- and αvβ5-integrin targeting agents. The method has been shown to promote normal cardiac angiogenesis, endothelial cell...